Company intelligence / Profile preview
Cellular Logistics
Madison, Wisconsin, United Statescellogistics.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Solus™ has shown promising results in restoring heart function in a dose-dependent fashion in mouse models. Data was presented at the American Heart Association Scientific Sessions in November 2023. The product exhibits angiogenic, anti-inflammatory, and cardio-reparative properties without adverse immune reactions in laboratory assays and immunocompetent hosts[6][7].
- Therapeutic areas
- Cardiovascular
- Modalities
- BiomaterialCell therapyRegenerative medicine
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Allele Biotechnology Inc.
Beyond the preview
Go deeper on Cellular Logistics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cellular Logistics.